Pharmacokinetics/Pharmacodynamics
Aarab R, van Es J, de Pont AC, Vroom MB, Middeldorp
S. Monitoring of unfractionated heparin in critically ill
patients. Neth J Med. 2013;71(9):466-471. http://www.
njmonline.nl/njm/getarticle.php?v=71&i=9&p=466
Abdul-Aziz MH, Alffenaar JC, Bassetti M, et al.
Antimicrobial therapeutic drug monitoring in criti-
Med.
2020;46(6):1127-1153.
https://doi.org/10.1007/
s00134-020-06050-1
Abdul-Aziz MH, Dulhunty JM, Bellomo R, Lipman J,
Roberts JA. Continuous beta-lactam infusion in critically
2012;2(1):37. https://doi.org/10.1186/2110-5820-2-37
Abdul-Aziz MH, Hammond NE, Brett SJ, et al.
Prolonged vs intermittent infusions of β-lactam antibi-
otics in adults with sepsis or septic shock: a systematic
https://doi.org/10.1001/jama.2024.9803
Aldardeer NF, Alshreef MM, Alharbi EA, et al. Early
versus late antipseudomonal β-lactam antibiotic dose
adjustment in critically ill sepsis patients with acute
kidney injury: a prospective observational cohort study.
Open Forum Infect Dis. 2024;11(3):ofae059. https://doi.
org/10.1093/ofid/ofae059
Andus T, Geiger T, Hirano T, Kishimoto T, Heinrich
PC. Action of recombinant human interleukin 6,
interleukin 1 beta and tumor necrosis factor alpha on
the mRNA induction of acute-phase proteins. Eur J
Immunol. 1988;18(5):739-746. https://doi.org/10.1002/
eji.1830180513
Ariano RE, Sitar DS, Zelenitsky SA, et al. Enteric
absorption and pharmacokinetics of oseltamivir in
critically ill patients with pandemic (H1N1) influenza.
CMAJ.
2010;182(4):357-363.
https://doi.org/10.1503/
cmaj.092127
Barletta JF, Johnson SB, Nix DE, Nix LC, Erstad
BL. Population pharmacokinetics of aminoglyco-
sides in critically ill trauma patients on once-daily
regimens. J Trauma. 2000;49(5):869-872. https://doi.
org/10.1097/00005373-200011000-00013
Barletta JF, Mangram AJ, Byrne M, et al. Identifying
augmented renal clearance in trauma patients: valida-
tion of the Augmented Renal Clearance in Trauma
Surg.
2017;82(4):665-671.
https://doi.org/10.1097/
ta.0000000000001387
Barquist ES, Gomez-Fein E, Block EF, Collin G,
Alzamel H, Martinez O. Bioavailability of oral flucon-
azole in critically ill abdominal trauma patients with and
without abdominal wall closure: a randomized crossover
clinical trial. J Trauma. 2007;63(1):159-163. https://doi.
org/10.1097/01.ta.0000232011.59630.93
Bellomo R, Kellum JA, Wisniewski SR, Pinsky MR.
Effects of norepinephrine on the renal vasculature in
Med. 1999;159(4 pt 1):1186-1192. https://doi.org/10.1164/
ajrccm.159.4.9802055
Bersten AD, Hersch M, Cheung H, Rutledge FS, Sibbald
WJ. The effect of various sympathomimetics on the
regional circulations in hyperdynamic sepsis. Surgery.
1992;112(3):549-561.
https://www.surgjournal.com/
article/0039-6060(92)90260-7/abstract
Bickford
A,
Majercik
S,
Bledsoe
J,
et
al.
Weight-based enoxaparin dosing for venous thrombo-
embolism prophylaxis in the obese trauma patient. Am
J Surg. 2013;206(6):847-852. https://doi.org/10.1016/j.
amjsurg.2013.07.020
Bonnet F, Richard C, Glaser P, Lafay M, Guesde
R. Changes in hepatic flow induced by continuous
positive pressure ventilation in critically ill patients.
Crit
Care
Med.
1982;10(11):703-705.
https://doi.
org/10.1097/00003246-198211000-00001
Boucher BA, King SR, Wandschneider HL, et al.
Fluconazole
pharmacokinetics
in
burn
patients.
Antimicrob Agents Chemother. 1998;42(4):930-933.
https://doi.org/10.1128/aac.42.4.930
Boucher BA, Rodman JH, Jaresko GS, Rasmussen SN,
Watridge CB, Fabian TC. Phenytoin pharmacokinetics
in critically ill trauma patients. Clin Pharmacol Ther.
1988;44(6):675-683. https://doi.org/10.1038/clpt.1988.211
Bouglé A, Dujardin O, Lepère V, et al. PHARMECMO:
therapeutic drug monitoring and adequacy of cur-
rent dosing regimens of antibiotics in patients on
Med.
2019;38(5):493-497.
https://doi.org/10.1016/j.
accpm.2019.02.015
Brandstrup B, Svensen C, Engquist A. Hemorrhage and
operation cause a contraction of the extracellular space